Scarica l'app Stockscreener
0.00
100.00%
-0.054
Precedente Chiudi:
$0.054
Aprire:
$0
Volume 24 ore:
0
Relative Volume:
0.00
Capitalizzazione di mercato:
$N/A
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
-100.00%
1M Prestazione:
-100.00%
6M Prestazione:
-100.00%
1 anno Prestazione:
-100.00%
Intervallo 1D:
$0.00
$0.00
Intervallo di 1 settimana:
$0.00
$0.072
Portata 52W:
$0.00
$34.93
Geovax Labs Inc Stock (GOVXW) Company Profile
Nome
Geovax Labs Inc
Settore
Industria
Telefono
678 384 7220
Indirizzo
1900 Lake Park Drive, Suite 380, Smyrna
Confronta GOVXW con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
GOVXW
Geovax Labs Inc
|
0.00 | 0 | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
483.49 | 124.48B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
625.60 | 67.45B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
583.62 | 35.60B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
266.83 | 34.53B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
274.78 | 29.15B | 3.81B | -644.79M | -669.77M | -6.24 |
Geovax Labs Inc Borsa (GOVXW) Ultime notizie
Short Interest in GeoVax Labs, Inc. (NASDAQ:GOVX) Drops By 12.3% - Defense World
GeoVax Labs CEO Makes Bold Stock Purchase! - TipRanks
Geovax labs CEO David Dodd acquires $10,800 in common stock - Investing.com India
Geovax Labs stock hits 52-week low at $1.09 amid market challenges - Investing.com
Roth Capital Forecasts GeoVax Labs FY2029 Earnings - Defense World
GeoVax Labs (NASDAQ:GOVX) Earns Buy Rating from D. Boral Capital - Defense World
GeoVax Labs Advances Vaccine Trials and Expands Operations - TipRanks
GeoVax Labs Earnings Call: Mixed Sentiments and Strategic Plans - TipRanks
GeoVax Reports 2024 Year-End Financial Results and Provides Business Update - TradingView
Geovax Labs Inc (GOVX) Q4 2024 Earnings Call Highlights: Strategic Advances Amid Financial ... - Yahoo Finance
Geovax Labs Inc (GOVX) Q4 2024 Earnings Call Highlights: Strategic Advances Amid Financial Challenges - GuruFocus.com
Earnings call transcript: GeoVax Q4 2024 highlights ongoing challenges By Investing.com - Investing.com South Africa
GEOVAX LABS Earnings Results: $GOVX Reports Quarterly Earnings - Nasdaq
GeoVax Labs Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Earnings call transcript: GeoVax Q4 2024 highlights ongoing challenges - Investing.com
What's Next: Geovax Labs's Earnings Preview - Benzinga
GEOVAX LABS Earnings Preview: Recent $GOVX Insider Trading, Hedge Fund Activity, and More - Nasdaq
GeoVax Labs IncEnters Placement Agency And Securities Purchase Agreements With A.G.P./Alliance Global PartnersSEC Filing - MarketScreener
GeoVax Labs Inc expected to post a loss of 77 cents a shareEarnings Preview - TradingView
GeoVax Prepares to Announce Fourth Quarter and Full Year 2024 Financial Results - citybuzz -
GeoVax to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Corporate Update on March 27, 2025 - Yahoo Finance
GeoVax Labs, Inc. (NASDAQ:GOVX) Given Average Recommendation of “Buy” by Analysts - Defense World
International - Financial Content
GeoVax Establishing Strategic Presence in Europe With Initial Footprint in the UK - Yahoo Finance
GeoVax CEO to Present at 37th Annual Roth Conference, Highlighting COVID-19 Vaccine and Cancer Therapy Research - citybuzz -
GeoVax to Present at the 37th Annual Roth Conference - Yahoo Finance
GeoVax Labs, Inc. (NASDAQ:GOVX) Short Interest Up 35.5% in February - Defense World
News - Financial Content
Geovax Labs Inc (NASDAQ: GOVX) Could Fell Another -164.9% - Stocks Register
GeoVax Highlights the Critical Role of MVA-Based Vaccines in U.S. Biodefense Strategy - Yahoo Finance
GeoVax Labs’ (GOVX) “Buy” Rating Reiterated at D. Boral Capital - Defense World
GeoVax Response to WHO's Third Declaration of Mpox as a Public Health Emergency of International Concern - Yahoo Finance
GeoVax Labs (GOVX) Projected to Post Earnings on Thursday - Defense World
GeoVax Highlights the Role of MVA-Based Vaccines in Advancing Public Health Preparedness - Yahoo Finance
Mpox Clade 1 in the U.S. Highlights the Need for Vaccine Supply Diversification - Yahoo Finance
GeoVax Labs, Inc. (NASDAQ:GOVX) Receives Average Rating of “Buy” from Analysts - Defense World
GeoVax Pledges Continued Support for Vaccine Innovation, Transparency, and Public Health - Yahoo Finance
GeoVax shareholders approve warrant exercises - MSN
GeoVax to Highlight Mpox Vaccine Development at Emerging Growth Conference - citybuzz -
GeoVax Congratulates Dr. Valerie Montgomery Rice on Receiving the 2025 Healthcare Champions Lifetime Achievement Award - Yahoo Finance
Was Geovax Labs Inc (GOVX)’s session last reading good? - US Post News
GeoVax Anticipates Significant 2025 Progress With Catalyst-Rich Milestones Across Key Programs - Financial Content
Stock Surge: Geovax Labs Inc (GOVX) Closes at 1.77, Marking a -7.33 Increase/Decrease - The Dwinnex
Analysts review Geovax Labs Inc’s rating - Knox Daily
GeoVax to Present Strategic Vision for Cancer and Infectious Disease Treatments at Major Biotech Conference - citybuzz -
GeoVax to Showcase Advancements in Vaccines & Immunotherapies at the 2025 BIO CEO & Investor Conference - Yahoo Finance
Trump's Stargate Initiative: A New Era For Healthcare Innovation - Evrim Ağacı
GeoVax Announces Strategic Integration of AI in Support of President Trump's Stargate Initiative - Yahoo Finance
GeoVax Labs (NASDAQ:GOVXW) Shares Down 11.3% – Here’s Why - Defense World
Strengthening America's Biosecurity: GeoVax Advances Domestic Vaccine Capability - Yahoo Finance
GeoVax Advanced MVA Manufacturing Process: Aimed to Enhance Vaccine Supply Worldwide - Yahoo Finance
Geovax Labs Inc Azioni (GOVXW) Dati Finanziari
Non sono disponibili dati finanziari per Geovax Labs Inc (GOVXW). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
2.00%
Capitalizzazione:
|
Volume (24 ore):